XERS News and Press, Xeris Pharmaceuticals Inc. From 10/25/21

Remark Holdings (NASDAQ:MARK) +266%. Sonim Technologies (NASDAQ:SONM) +96%. Creatd (NASDAQ:CRTD) +69% announces second NFT drop, includes photographs of former President Donald Trump PAE Incorporated (NASDAQ:PAE) +67% Amentum to buy PAE in an all-cash deal valued at ~$1.9 ...

Collaboration and option to license the XeriJect™ technology Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology, today ann...

Qualcomm and SSW Partners outbid Magna to buy Veoneer. Veoneer to pay a termination fee of $110 million to Magna. Meredith Corporation acquired by IAC/InterActiveCorp and Gray Television. For further details see: Merger Arbitrage Mondays - Qualcomm And SSW Partners Win T...

Xeris Pharmaceuticals, Inc. and Strongbridge Biopharma plc are now subsidiaries of Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) Xeris Pharmaceuticals, Inc. (“Xeris”), a pharmaceutical company leveraging its novel formulation technology platforms to develop and...

DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the "Court") has approved the previously announced proposed a...

Xeris Pharmaceuticals, Inc. is purchasing Strongbridge Biopharma in a stock swap and contingent value rights transaction. Assuming approval of Strongbridge’s Recorlev, the combination will have three products on the market in 2022 while enjoying ~$50 million of merger synergies...

The Five9 - Zoom deal takes a turn for the worse. The spread on the Five9 deal drops further into negative territory. Tencent's acquisition of Sogou finally goes through almost a year after announcement. For further details see: Merger Arbitrage Mondays: Five9 Investors ...

Kansas City Southern leaves Canadian National Railway at the altar. Goldman Sachs Group uses its stock to acquire GreenSky for $2.24 billion by giving GreenSky shareholders 0.03 shares of Goldman Sachs. Veoneer receives an updated non-binding proposal from Qualcomm. For...

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable drug formulations, today announced that Paul R. Edick, Chairman and Chief Executive Officer of Xeris Pharmaceuticals, wil...

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) (“Xeris”) today announced that its stockholders have voted to approve the previously announced proposed acquisition of Strongbridge Biopharma plc (NASDAQ: SBBP) (“Strongbridge”) by Xeris. At the special meeting o...